PlainRecalls
FDA Devices Moderate Class II Terminated

First SIGN SARS-CoV-2 Antigen Test

Reported: April 13, 2022 Initiated: March 4, 2022 #Z-0892-2022

Product Description

First SIGN SARS-CoV-2 Antigen Test

Reason for Recall

Frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not received FDA Emergency Use Authorization, nor have these tests been cleared or approved by FDA for commercial distribution in the U.S.

Details

Recalling Firm
WHPM Inc.
Units Affected
535,755 tests
Distribution
U.S.: CA, FL, LA, MA and TX O.U.S.: N/A
Location
Irwindale, CA

Frequently Asked Questions

What product was recalled?
First SIGN SARS-CoV-2 Antigen Test. Recalled by WHPM Inc.. Units affected: 535,755 tests.
Why was this product recalled?
Frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not received FDA Emergency Use Authorization, nor have these tests been cleared or approved by FDA for commercial distribution in the U.S.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 13, 2022. Severity: Moderate. Recall number: Z-0892-2022.